Diabetes 54:3474-3483, 2005 © 2005 by the American Diabetes Association, Inc. Skeletal Muscle Insulin Signaling Defects Downstream of Phosphatidylinositol 3-Kinase at the Level of Akt Are Associated With Impaired Nonoxidative Glucose Disposal in HIV Lipodystrophy
1 Department of Infectious Diseases, Hvidovre University Hospital, Hvidovre, Copenhagen
More than 40% of HIV-infected patients on highly active antiretroviral therapy (HAART) experience fat redistribution (lipodystrophy), a syndrome associated with insulin resistance primarily affecting insulin-stimulated nonoxidative glucose metabolism (NOGMins). Skeletal muscle biopsies, obtained from 18 lipodystrophic nondiabetic patients (LIPO) and 18 nondiabetic patients without lipodystrophy (NONLIPO) before and during hyperinsulinemic (40 mU · m–2 · min–1)-euglycemic clamps, were analyzed for insulin signaling effectors. All patients were on HAART. Both LIPO and NONLIPO patients were normoglycemic (4.9 ± 0.1 and 4.8 ± 0.1 mmol/l, respectively); however, NOGMins was reduced by 49% in LIPO patients (P < 0.001). NOGMins correlated positively with insulin-stimulated glycogen synthase activity (I-form, P < 0.001, n = 36). Glycogen synthase activity (I-form) correlated inversely with phosphorylation of glycogen synthase sites 2+2a (P < 0.001, n = 36) and sites 3a+b (P < 0.001, n = 36) during clamp. Incremental glycogen synthase-kinase–3
Address correspondence and reprint requests to Steen B. Haugaard, MD, Clinical Research Unit 136, Hvidovre University Hospital, DK 2650 Hvidovre, Copenhagen, Denmark. E-mail: sbhau{at}dadlnet.dk
Abbreviations: FFA, free fatty acid; FV, fractional velocity; G6P, glucose-6-phosphate; GDR, glucose disposal rate; GOX, glucose oxidation; HAART, highly active antiretroviral therapy; IRS-1, insulin receptor substrate-1; NOGM, nonoxidative glucose metabolism; NOGMins, insulin-stimulated nonoxidative glucose metabolism; PI, phosphatidylinositol; TBST, Tris-buffered saline with 1% Tween
This article has been cited by other articles:
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||